You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mRNA-1647

Showing 1 - 25 of 784
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cytomegalovirus Infection Trial in Boston (mRNA-1647, Placebo)

Not yet recruiting
  • Cytomegalovirus Infection
  • mRNA-1647
  • Placebo
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 4, 2023

Cytomegalovirus Infection Trial in North Hollywood, San Diego, Honolulu (mRNA-1647, Placebo)

Active, not recruiting
  • Cytomegalovirus Infection
  • mRNA-1647
  • Placebo
  • North Hollywood, California
  • +2 more
Dec 3, 2022

Cytomegalovirus Infection Trial in United States (mRNA-1647, Placebo)

Completed
  • Cytomegalovirus Infection
  • mRNA-1647
  • Placebo
  • Sacramento, California
  • +8 more
Jan 11, 2023

Cytomegalovirus Infection Trial in United States (mRNA-1647, Placebo)

Not yet recruiting
  • Cytomegalovirus Infection
  • mRNA-1647
  • Placebo
  • Birmingham, Alabama
  • +25 more
Nov 10, 2023

SARS-CoV-2, Seasonal Influenza, Respiratory Syncytial Virus Trial in United States (mRNA-1273, mRNA-1010, mRNA-1345)

Recruiting
  • SARS-CoV-2
  • +3 more
  • mRNA-1273
  • +4 more
  • Hollywood, Florida
  • +7 more
May 25, 2022

Cytomegalovirus Infection Trial in United States (mRNA-1647, mRNA-1443, Placebo)

Completed
  • Cytomegalovirus Infection
  • mRNA-1647
  • +2 more
  • Hollywood, Florida
  • +3 more
Jan 13, 2021

Cytomegalovirus Trial in Canada, United Kingdom, United States (mRNA-1647, Placebo)

Recruiting
  • Cytomegalovirus
  • mRNA-1647
  • Placebo
  • La Mesa, California
  • +60 more
Jan 12, 2023

Cytomegalovirus Infection Trial in Worldwide (mRNA-1647, Placebo)

Recruiting
  • Cytomegalovirus Infection
  • mRNA-1647
  • Placebo
  • Phoenix, Arizona
  • +165 more
Jan 13, 2023

The Effect of Covid-19 Vaccination in Patients Undergoing IVF

Not yet recruiting
  • Covid-19 Vaccination
    • (no location specified)
    Sep 30, 2021

    SARS-CoV-2 Trial in United States (mRNA-1273.211, mRNA-1273, mRNA-1273.617.2)

    Active, not recruiting
    • SARS-CoV-2
    • mRNA-1273.211
    • +6 more
    • Sacramento, California
    • +22 more
    Nov 16, 2022

    Seasonal Influenza Trial in United States (mRNA-1011.1, mRNA-1011.2, mRNA-1012.1)

    Recruiting
    • Seasonal Influenza
    • mRNA-1011.1
    • +5 more
    • Lakewood, California
    • +21 more
    Apr 12, 2023

    SARS-CoV-2, Influenza, RSV Trial in Australia, United Kingdom, United States (mRNA-1010, mRNA-1345, mRNA-1273.214)

    Recruiting
    • SARS-CoV-2
    • +2 more
    • mRNA-1010
    • +4 more
    • DeLand, Florida
    • +29 more
    Jan 23, 2023

    Respiratory Syncytial Virus, Human Metapneumovirus Trial in Worldwide (mRNA-1345, mRNA-1365, Placebo)

    Recruiting
    • Respiratory Syncytial Virus
    • Human Metapneumovirus
    • mRNA-1345
    • +3 more
    • Andalusia, Alabama
    • +72 more
    Feb 15, 2023

    Influenza Immunization Trial in Australia (H3 mRNA / LNP Vaccine, Quadrivalent recombinant influenza Vaccine (RIV4))

    Recruiting
    • Influenza Immunization
    • H3 mRNA / LNP Vaccine
    • Quadrivalent recombinant influenza Vaccine (RIV4)
    • Herston, Queensland, Australia
    • +3 more
    May 1, 2023

    Lyme Disease Trial in United States (mRNA-1975, mRNA-1982, Placebo)

    Recruiting
    • Lyme Disease
    • mRNA-1975
    • +2 more
    • Milford, Connecticut
    • +19 more
    Jul 26, 2023

    Norovirus Acute Gastroenteritis Trial in United States (mRNA-1403, mRNA-1405, Placebo)

    Not yet recruiting
    • Norovirus Acute Gastroenteritis
    • mRNA-1403
    • +2 more
    • Long Beach, California
    • +14 more
    Aug 7, 2023

    Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

    Not yet recruiting
    • Adrenal Cortical Carcinoma
    • +3 more
    • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
    • Shanghai, Shanghai, China
      Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
    Nov 19, 2023

    Seasonal Influenza Trial in United States (mRNA-1030, mRNA-1020, mRNA-1010)

    Completed
    • Seasonal Influenza
    • mRNA-1030
    • +3 more
    • Phoenix, Arizona
    • +14 more
    Dec 5, 2022

    Respiratory Syncytial Virus Trial in United States (Placebo, mRNA-1345, Fluzone HD)

    Not yet recruiting
    • Respiratory Syncytial Virus
    • Placebo
    • +2 more
    • Scottsdale, Arizona
    • +32 more
    Sep 23, 2023

    COVID-19 Trial in United States (mRNA-CR-04 vaccine 10µg, mRNA-CR-04 vaccine 30µg, mRNA-CR-04 vaccine 100µg)

    Not yet recruiting
    • COVID-19
    • mRNA-CR-04 vaccine 10μg
    • +3 more
    • San Diego, California
    • +3 more
    Aug 1, 2023

    COVID-19 Trial in Canada, United Kingdom, United States (mRNA-1283.222, mRNA-1273.222)

    Recruiting
    • COVID-19
    • mRNA-1283.222
    • mRNA-1273.222
    • Birmingham, Alabama
    • +209 more
    Apr 13, 2023

    Heart Transplant Rejection Trial in Helsinki (Cell-free DNA)

    Recruiting
    • Heart Transplant Rejection
    • Cell-free DNA
    • Helsinki, Uusimaa, Finland
      Helsinki University Hospital
    Oct 2, 2023

    SARS-CoV-2 Trial in United States (mRNA-1273, Placebo)

    Recruiting
    • SARS-CoV-2
    • mRNA-1273
    • +2 more
    • Banning, California
    • +48 more
    Jan 5, 2023

    SARS-CoV-2, Influenza Trial in United States (mRNA-1073, mRNA-1010, mRNA-1273)

    Active, not recruiting
    • SARS-CoV-2
    • Influenza
    • mRNA-1073
    • +3 more
    • Hollywood, Florida
    • +13 more
    Oct 5, 2022

    Advanced Solid Tumor Trial in Shanghai (Personalized neoantigen tumor vaccine)

    Recruiting
    • Advanced Solid Tumor
    • Personalized neoantigen tumor vaccine
    • Shanghai, Shanghai, China
      Ruijin Hospital Shanghai Jiaotong University School of Medicine
    Jun 24, 2023